383 related articles for article (PubMed ID: 38392293)
21. Plasma PPi Deficiency Is the Major, but Not the Exclusive, Cause of Ectopic Mineralization in an Abcc6
Zhao J; Kingman J; Sundberg JP; Uitto J; Li Q
J Invest Dermatol; 2017 Nov; 137(11):2336-2343. PubMed ID: 28652107
[TBL] [Abstract][Full Text] [Related]
22. Etidronate prevents, but does not reverse, ectopic mineralization in a mouse model of pseudoxanthoma elasticum (
Li Q; Kingman J; Sundberg JP; Levine MA; Uitto J
Oncotarget; 2018 Jul; 9(56):30721-30730. PubMed ID: 30112102
[TBL] [Abstract][Full Text] [Related]
23. Early arterial calcification does not correlate with bone loss in pseudoxanthoma elasticum.
Martin L; Hoppé E; Kauffenstein G; Omarjee L; Navasiolava N; Henni S; Willoteaux S; Leftheriotis G
Bone; 2017 Oct; 103():88-92. PubMed ID: 28658601
[TBL] [Abstract][Full Text] [Related]
24. Pyrophosphates as a major inhibitor of matrix calcification in Pseudoxanthoma elasticum.
Dabisch-Ruthe M; Kuzaj P; Götting C; Knabbe C; Hendig D
J Dermatol Sci; 2014 Aug; 75(2):109-20. PubMed ID: 24907773
[TBL] [Abstract][Full Text] [Related]
25. Juxta-articular joint-capsule mineralization in CD73 deficient mice: similarities to patients with NT5E mutations.
Li Q; Price TP; Sundberg JP; Uitto J
Cell Cycle; 2014; 13(16):2609-15. PubMed ID: 25486201
[TBL] [Abstract][Full Text] [Related]
26. Oral administration of pyrophosphate inhibits connective tissue calcification.
Dedinszki D; Szeri F; Kozák E; Pomozi V; Tőkési N; Mezei TR; Merczel K; Letavernier E; Tang E; Le Saux O; Arányi T; van de Wetering K; Váradi A
EMBO Mol Med; 2017 Nov; 9(11):1463-1470. PubMed ID: 28701330
[TBL] [Abstract][Full Text] [Related]
27. ABCC6-mediated ATP secretion by the liver is the main source of the mineralization inhibitor inorganic pyrophosphate in the systemic circulation-brief report.
Jansen RS; Duijst S; Mahakena S; Sommer D; Szeri F; Váradi A; Plomp A; Bergen AA; Oude Elferink RP; Borst P; van de Wetering K
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1985-9. PubMed ID: 24969777
[TBL] [Abstract][Full Text] [Related]
28. Alteration of Extracellular Nucleotide Metabolism in Pseudoxanthoma Elasticum.
Kauffenstein G; Yegutkin GG; Khiati S; Pomozi V; Le Saux O; Leftheriotis G; Lenaers G; Henrion D; Martin L
J Invest Dermatol; 2018 Aug; 138(8):1862-1870. PubMed ID: 29501384
[TBL] [Abstract][Full Text] [Related]
29. The molecular and physiological roles of ABCC6: more than meets the eye.
Le Saux O; Martin L; Aherrahrou Z; Leftheriotis G; Váradi A; Brampton CN
Front Genet; 2012; 3():289. PubMed ID: 23248644
[TBL] [Abstract][Full Text] [Related]
30. Pseudoxanthoma elasticum - Genetics, pathophysiology, and clinical presentation.
Pfau K; Lengyel I; Ossewaarde-van Norel J; van Leeuwen R; Risseeuw S; Leftheriotis G; Scholl HPN; Feltgen N; Holz FG; Pfau M
Prog Retin Eye Res; 2024 May; 102():101274. PubMed ID: 38815804
[TBL] [Abstract][Full Text] [Related]
31. Plasma inorganic pyrophosphate and alkaline phosphatase in patients with pseudoxanthoma elasticum.
Sánchez-Tévar AM; García-Fernández M; Murcia-Casas B; Rioja-Villodres J; Carrillo JL; Camacho M; Van Gils M; Sánchez-Chaparro MA; Vanakker O; Valdivielso P
Ann Transl Med; 2019 Dec; 7(24):798. PubMed ID: 32042814
[TBL] [Abstract][Full Text] [Related]
32. The effects of bisphosphonates on ectopic soft tissue mineralization caused by mutations in the ABCC6 gene.
Li Q; Sundberg JP; Levine MA; Terry SF; Uitto J
Cell Cycle; 2015; 14(7):1082-9. PubMed ID: 25607347
[TBL] [Abstract][Full Text] [Related]
33. Novel Treatments for PXE: Targeting the Systemic and Local Drivers of Ectopic Calcification.
Jacobs IJ; Li Q
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894722
[TBL] [Abstract][Full Text] [Related]
34. Plasma Level of Pyrophosphate Is Low in Pseudoxanthoma Elasticum Owing to Mutations in the ABCC6 Gene, but It Does Not Correlate with ABCC6 Genotype.
Kozák E; Bartstra JW; de Jong PA; Mali WPTM; Fülöp K; Tőkési N; Pomozi V; Risseeuw S; Norel JO; van Leeuwen R; Váradi A; Spiering W
J Clin Med; 2023 Jan; 12(3):. PubMed ID: 36769695
[TBL] [Abstract][Full Text] [Related]
35. Paediatric pseudoxanthoma elasticum with cardiovascular involvement.
Li Q; Baker J; Kowalczyk J; Jiang Q; Uitto J; Schachner L
Br J Dermatol; 2013 Nov; 169(5):1148-51. PubMed ID: 23746223
[TBL] [Abstract][Full Text] [Related]
36. Genetics in arterial calcification: lessons learned from rare diseases.
Nitschke Y; Rutsch F
Trends Cardiovasc Med; 2012 Aug; 22(6):145-9. PubMed ID: 23122642
[TBL] [Abstract][Full Text] [Related]
37. Pseudoxanthoma elasticum.
Germain DP
Orphanet J Rare Dis; 2017 May; 12(1):85. PubMed ID: 28486967
[TBL] [Abstract][Full Text] [Related]
38. The vascular phenotype in Pseudoxanthoma elasticum and related disorders: contribution of a genetic disease to the understanding of vascular calcification.
Lefthériotis G; Omarjee L; Le Saux O; Henrion D; Abraham P; Prunier F; Willoteaux S; Martin L
Front Genet; 2013; 4():4. PubMed ID: 23408347
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous features of pseudoxanthoma elasticum in a patient with generalized arterial calcification of infancy due to a homozygous missense mutation in the ENPP1 gene.
Li Q; Schumacher W; Jablonski D; Siegel D; Uitto J
Br J Dermatol; 2012 May; 166(5):1107-11. PubMed ID: 22229486
[TBL] [Abstract][Full Text] [Related]
40. Inorganic Pyrophosphate Plasma Levels Are Decreased in Pseudoxanthoma Elasticum Patients and Heterozygous Carriers but Do Not Correlate with the Genotype or Phenotype.
Van Gils M; Depauw J; Coucke PJ; Aerts S; Verschuere S; Nollet L; Vanakker OM
J Clin Med; 2023 Feb; 12(5):. PubMed ID: 36902680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
